Prospects for predicting and stopping the development of type 1 of diabetes
- 1 September 2001
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Endocrinology & Metabolism
- Vol. 15 (3) , 371-389
- https://doi.org/10.1053/beem.2001.0152
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- Association between infant growth before onset of juvenile type-1 diabetes and autoantibodies to IA-2The Lancet, 2000
- Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes Registry.Diabetes Care, 2000
- Exposure of human islets to cytokines can result in disproportionately elevated proinsulin releaseJournal of Clinical Investigation, 1999
- Epidemiology, Clinical Aspects, and Biology of IDDM Patients Under Age 40 Years: Comparison of data from Antwerp with complete ascertainment with data from Belgium with 40% ascertainment. The Belgian Diabetes RegistryDiabetes Care, 1997
- Meta-Analysis of Nicotinamide Treatment in Patients With Recent-Onset IDDMDiabetes Care, 1996
- Isohormonal therapy of endocrine autoimmunityImmunology Today, 1995
- A Comparison of Childhood and Adult Type I Diabetes MellitusNew England Journal of Medicine, 1989
- A Randomized Trial of Intensive Insulin Therapy in Newly Diagnosed Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1989
- Factors Associated with Early Remission of Type I Diabetes in Children Treated with CyclosporineNew England Journal of Medicine, 1988
- Epidemiologic Approach to the Etiology of Type I Diabetes Mellitus and Its ComplicationsNew England Journal of Medicine, 1987